Results 231 to 240 of about 92,388 (260)

Development of High Affinity Selective VIP1 Receptor Agonists

Peptides, 1997
Philippe Gourlet, André Vandermeers, Pascale Vertongen   +2 more
exaly  

A fragment of vasoactive intestinal peptide, VIP(10–28), is an antagonist of VIP in the colon carcinoma cell line, HT29

Peptides, 1986
S B Jones, D B Bylund
exaly  

Developmental Dysfunction of VIP Interneurons Impairs Cortical Circuits

Neuron, 2017
Renata Batista-Brito, Martin Vinck, Katie A Ferguson   +2 more
exaly  

The VIP'S

Film Quarterly, 1963
openaire   +2 more sources

The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors

Peptides, 1996
Philippe Gourlet, Jean-Pierre Vilardaga, Philippe De Neef   +2 more
exaly  

Variable influence on projection (VIP) for OPLS models and its applicability in multivariate time series analysis

Chemometrics and Intelligent Laboratory Systems, 2015
BEATRIZ Galindo-Prieto, Lennart Eriksson, Johan Trygg   +2 more
exaly  

Caring for VIPs in the emergency department: Are they VIPs or patients?

The American Journal of Emergency Medicine, 2018
Ali, Pourmand, Maxine, LeSaux, Jesse M, Pines, Robert, Shesser   +3 more
openaire   +2 more sources

Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain

International Journal of Pharmaceutics, 2004
Christine Dufes, Ijeoma F Uchegbu, Andreas G Schätzlein   +2 more
exaly  

VIP’s

Nursing, 2020
openaire   +1 more source

VIP-ellipticine derivatives inhibit the growth of breast cancer cells

Life Sciences, 2002
Terry W Moody, G Czerwinski, Christopher J Michejda   +2 more
exaly